Seaport and Hemab Therapeutics Launch IPOs, Raising $556 Million

Seaport Therapeutics and Hemab Therapeutics both launched on Wall Street Thursday, contributing to a recent surge of initial public offerings from drugmakers. The two companies together raised $556 million.

These IPOs are part of a larger trend this year, with multiple large IPOs collectively generating nearly $3.2 billion. Seaport Therapeutics and Hemab Therapeutics represent the latest biotechs to enter the public market during this period of increased activity.
n

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 30, 2026

Author

GOAI